Skip to main content

Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Brain Injury

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1182))

Abstract

Neurological dysfunction and death are common events leading to acute and chronic neurodegenerative diseases. Neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease account for a significant and increasing proportion of morbidity and mortality in the developed world. Ganoderma lucidum (G. lucidum, Lingzhi), one of highly nutritious and significantly effective medicinal herbs, has been used for clinical applications for thousands of years. Several researches have shown that it has a wide range of brain damage protection, such as amelioration of Alzheimer’s disease, therapeutic effect on epilepsy, and the protective effect on neural cells in stroke injury. This chapter reviews the neuroprotective effects of G. lucidum and its extracts on brain injury diseases, including Alzheimer’s disease, Parkinson’s disease, stroke, epilepsy, and other neurodegenerative diseases, and the potential clinical applications.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Lane CA, Hardy J, Schott JM (2018) Alzheimer’s disease. Eur J Neurol 25(1):59–70

    Article  CAS  PubMed  Google Scholar 

  2. Ferri CP, Martin P, Carol B, Henry B, Laura F, Mary G (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503):2112–2117

    Article  PubMed  PubMed Central  Google Scholar 

  3. Zhao C, Zhang C, Xing Z, Ahmad Z, Li JS, Chang MW (2019) Pharmacological effects of natural Ganoderma and its extracts on neurological diseases: a comprehensive review. Int J Biol Macromol 121:1160–1178

    Article  CAS  PubMed  Google Scholar 

  4. Yuan DJ, Zhang YF, Yao CX (2011) Effects of Ganoderma lucidum polysaccharides on synapsis and hippocampal Synaptophysin expression in Alzheimer’s rats model. Chin J Exp Tradit Med Formulae 17(3):151–155

    CAS  Google Scholar 

  5. Lai CS, Yu MS, Yuen WH, So KF, Zee SY, Chang RC (2008) Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res 1190:215–224

    Article  CAS  PubMed  Google Scholar 

  6. McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol 126(4):479–497

    Article  CAS  PubMed  Google Scholar 

  7. Cai Q, Li Y, Pei G (2017) Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation 14(1):63

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Guo YJ, Yuan H, Gan SW, Li L (2006) Protective effect of Ganoderma lucidum polysaccharide on the brain tissue of rat model of Alzheimer′s disease induced by β-amyloid protein fragment 25–35. Chin J Histochem Cytochem 15(4):447–451

    CAS  Google Scholar 

  9. Wang BH, Yuan H, Lv ZH (2007) Effects of Ganoderma lucidum polysaccharide on the expression of interleukin-6 in the hippocampus of the rats with the learning and memory dysfunction. Stroke Nerv Dis 14(4):206–209

    Google Scholar 

  10. Ajith TA, Sudheesh NP, Roshny D, Abishek G, Janardhanan KK (2009) Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. Exp Gerontol 44(3):219–223

    Article  CAS  PubMed  Google Scholar 

  11. Mohsenzadegan M, Mirshafiey A (2012) The immunopathogenic role of reactive oxygen species in Alzheimer disease. Iran J Allergy Asthma Immunol 11(3):203–216

    CAS  PubMed  Google Scholar 

  12. Guo YJ, Yuan H, Zhang LN (2006) Effects of Ganoderma lucidum polysaccharides on antioxidant ability and modality in the hippocampus of AD rats. Acta Anatomica Sinica 37(5):509–513

    CAS  Google Scholar 

  13. Yan T, Chen SB, Xu L, Yang L (2011) Effect of Ganoderma lucidum polysaccharides on learning and memory ability and oxygen stress of model rats with Alzheimer’s disease. Shaanxi Med J 40(4):387–389

    CAS  Google Scholar 

  14. Huang YP, Liu BJ, Yu NH, Kong XL (2008) An ultramicroscopy observation of protective effects of triterpenoids from Ganoderma lucidum on brain of Alzheimer disease model rats. J Guiyang Med Coll 33(6):662–664

    CAS  Google Scholar 

  15. Yu HN, Huang YP, Luo J (2008) The effect of Ganodermo Lucidum triterpenoids on catalase, acetylcholinesterase, superoxide dismutase and malondialdehyde contents in Alzheimer disease rat. J Guiyang Med Coll 33(6):640–642

    CAS  Google Scholar 

  16. Yang HM, Wang L, Chen J, Li YP (2009) Effects of Ganoderma lucidum polysaccharides on the ultrastructure and antioxidative capacity of hippocampus in Alzheimer’s disease-like rats. Chin J Gerontol 29(18):2351–2353

    CAS  Google Scholar 

  17. Zhou Y, Qu ZQ, Zeng YS, Lin YK, Li Y, Chung P (2012) Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol 64(7–8):673–680

    Article  PubMed  Google Scholar 

  18. Guo YJ, Li P, Yuan H (2008) Relationship between effects of Ganoderma lucidum polysaccharides on learning and memory in Alzheimer’s disease rats and apoptosis of hippocampus cells. Chin J Anat 31(3):376–378

    CAS  Google Scholar 

  19. Li G, Yuan H, Li L (2007) Effects of Ganoderma lucidum polysaccharide on c-fos expression in the hippocampus of Alzheimer’s disease model rats. Chin J Histochem Cytochem 16(6):727–732

    CAS  Google Scholar 

  20. Zhang YP, Yuan H, Li L (2008) Effects of Ganoderma lucidum polysaccharides on caspase-3 and fasl expressions in the hippocampus of Alzheimer disease model rats. Chin J Histochem Cytochem 17(5):484–489

    CAS  Google Scholar 

  21. Zhang Y, Luo J, Huang NH (2016) Effects of Ganoderma lucidum triterpenoids on apoptosis of brain tissue of Alzheimer disease model rat. J Guiyang Med Coll 41(5):532–534

    CAS  Google Scholar 

  22. Zengin G, Sarikurkcu C, Gunes E, Uysal A, Ceylan R, Uysal S (2015) Two Ganoderma species: profiling of phenolic compounds by HPLC-DAD, antioxidant, antimicrobial and inhibitory activities on key enzymes linked to diabetes mellitus, Alzheimer’s disease and skin disorders. Food Funct 6(8):2794–2802

    Article  CAS  PubMed  Google Scholar 

  23. Zhang Y, Huang NH, Zhang XY (2011) Effect of Ganoderma lucidum triterpenoids on the learning and memory ability and brain glutamate levels in mice aging model. Neurol Neurorehabil 8(1):31–34

    CAS  Google Scholar 

  24. Zhang Y, Luo J, Huang NH (2012) Protective effects and mechanism of Ganoderma lucidum triterpenoids on learning and memory function of Alzheimer disease model animal. J Food Sci Biotechnol 31(7):741–744

    CAS  Google Scholar 

  25. Zhang Y, Luo J, Huang NH (2012) Influence of Ganoderma lucidum triterpenoids on learning memory function and the activity of T-AOC of Alzheimer disease model animals. Chin J Tradit Chin Med Pharm 9:2318–2321

    Google Scholar 

  26. Zhu WW, Liu ZL, Xu HW, Chu WZ, Ye QY, Xie AM (2005) Effect of the oil from Ganoderma lucidum spores on pathological changes in the substantia nigra and behaviors of MPTP-treated mice. Di Yi Jun Yi Da Xue Xue Bao 25(6):667–671

    PubMed  Google Scholar 

  27. Guo SS, Cui XL, Rausch WD (2016) Ganoderma lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress. Am J Neurodegener Dis 5(2):131–144

    PubMed  PubMed Central  Google Scholar 

  28. Ren ZL, Wang CD, Wang T, Ding H, Zhou M, Yang N (2018) Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacol Sin 40(4):441–450

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  29. Bao C (2014) Effect of Ganoderma lucidium spore on oxidative stress and inflammatory responses in rats with Parkinson’s disease. Pract Pharm Clin Rem 4:402–404

    Google Scholar 

  30. Zhang R, Xu S, Cai Y, Zhou M, Zuo X, Chan P (2011) Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation. Evid Based Complement Alternat Med 2011:15686

    Google Scholar 

  31. Zhu WW, Liu ZL, Xu HW (2007) Expressions of TNF-α and IL-1β in the substantia nigra of MPTP-induced mouse model of Parkinson’s disease and the regulation of Ganoderma spores oil. J Int Neurol Neurosurg 34(3):201–204

    Google Scholar 

  32. Xu PY, Yang HH, Liu ZL (2006) Effect of Ganoderma lucidum spore powder on degeneration of dopaminergic neurons induced by lipopolysaccharide. Chin J Nerv Ment Dis 32(3):262–264

    Google Scholar 

  33. Xie AM, Liu ZL, Chen L (2004) Study on ultrastructural changes of substantia nigra and effects of Ganoderma spores on the changes in experiment Parkinson’s disease rats. Chin J Nerv Ment Dis 30(1):11–13

    Google Scholar 

  34. Xie AM, Xue L (2008) Experiment on Ganoderma spore’s effect on caspase-3 in Parkinson’s disease. Chin J Clin Neurosci 16(6):601–605

    Google Scholar 

  35. Xie AM, Xue L, Liu M (2007) Dietary effects of Ganoderma spores on the expression of neurotransmitter in a Parkinson’s disease rat model. J Trop Med 7(11):1091–1093

    CAS  Google Scholar 

  36. Tang K, Zhang JT (2000) Progress in mechanisms of cerebral ischemia and therapeutic strategies. Chin New Drugs J 9(12):809–813

    Google Scholar 

  37. Zhao HB, Jiao LD, Wang SZ, Lin ZB (2005) Protective effect of Ganoderma lucidum sterol on focal cerebral ischemia and reperfusion. Chin J Neuroimmunol Neurol 12(2):114–117

    Google Scholar 

  38. Zhao HB, Wang SZ, He QH, Yuan L, Chen AF, Lin ZB (2005) Ganoderma total sterol (GS) and GS1 protect rat cerebral cortical neurons from hypoxia/reoxygenation injury. Life Sci 76(9):1027–1037

    Article  CAS  PubMed  Google Scholar 

  39. Zhang W, Zhang Q, Deng W, Li Y, Xing G, Shi X (2014) Neuroprotective effect of pretreatment with Ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus. Neural Regen Res 9(15):1446–1452

    Article  PubMed  PubMed Central  Google Scholar 

  40. Wang XZ, Li JG, Wang HY (2009) Effects of Ganoderma on the rate of neural apoptosis and mitochondrial transmembrane potential of the nerve cells in rats with cerebral ischemia/reperfusion. Med Innov China 6(20):15–18

    Google Scholar 

  41. Zhou ZY, Tang YP, Xiang J, Wua P, Jin HM, Wang Z (2010) Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol 131(1):154–164

    Article  CAS  PubMed  Google Scholar 

  42. Xuan M, Okazaki M, Iwata N, Asano S, Kamiuchi S, Matsuzaki H (2015) Chronic treatment with a water-soluble extract from the culture medium of Ganoderma lucidum mycelia prevents apoptosis and necroptosis in hypoxia/ischemia-induced injury of type 2 diabetic mouse brain. Evid Based Complement Alternat Med 2015:865986

    Article  PubMed  PubMed Central  Google Scholar 

  43. Li YW, Han LQ, Jin Y, Zhu WH (2017) Protective effect of Ganoderma lucidum polysaccharide sulfate on cerebral ischemia reperfusion injury in rats and its mechanism. J Jilin Univ (Med Ed) 43(4):679–684

    Google Scholar 

  44. Li YW, Chen LH, Han LQ, Zhou DP (2018) Influence of carboxymethylated Ganoderma lucidum polysaccharide pretreatment on cerebral ischemia-reperfusion injury in rats. Shandong Med J 58(4):12–16

    Google Scholar 

  45. Zhu KL, Xie LL, Liu H (2015) Effects of Ganoderma lucidum polysaccharide on expression of MAPK14, CaN and GSH-Px in cerebral cortex and hippocampus of epileptic rats. J Shanghai Univ Tradit Chin Med 5:65–68

    Google Scholar 

  46. Wang SQ, Li XJ, Jia ZM, Qin XY, Han YZ, Liu L (2011) Effect of Ganoderma lucidum spores on cytochrome C, mitochondrial Ca2 +, HSP70 and BDNF in brain of epilepsy rats. Chin J Pathophysiol 27(6):1053–1058

    CAS  Google Scholar 

  47. Wang H, Wang SQ (2006) Effect of Ganoderma lucidum spore powder on NMDAR1 immune response in cortex and hippocampus of rats with epilepsy. Heilongjiang Med Pharm 29(1):11–13

    Google Scholar 

  48. Zhu KL, Xie LL, Liu H (2015) Ganoderma lucidum polysaccharide on excitatory amino acid transporter in brain of epileptic rat. J Changchun Univ Chin Med 31(6):1104–1106

    Google Scholar 

  49. Zhu KL, Zhang SL, Wang SQ (2013) Effect of Ganoderma lucidum spores on the somatostatin and 5-HT in brain of epilepsy rats. Shanghai J Tradit Chin Med 4:75–78

    Google Scholar 

  50. Wang SQ, Li XJ, Qiu HB, Jiang ZM, Simon M, Ma XR (2014) Anti-epileptic effect of Ganoderma lucidum polysaccharides by inhibition of intracellular calcium accumulation and stimulation of expression of CaMKII alpha in epileptic hippocampal neurons. PLoS One 9(7):e102161

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Qiu WJ, Hu XW, Zhang ZC (2014) Research progress in the pathogenesis and treatment of epilepsy. Chin J Clin (Electron Ed) 8(10):101–105

    CAS  Google Scholar 

  52. Wang WQ, Wang SQ, Liu YX, Ma XR, Wang BX (2007) Effect of Ganoderma lucidum spores on IL-1β and c-Fos in the brain tissue of epilepsy rats. Chin J Pathophysiol 23(6):1149–1152

    Google Scholar 

  53. Wang WQ, Zhang ML, Yu HB, Li J (2012) Effects of Ganoderma lucidum spores on the expression of IL-2 and intracellular Ca2+ in brain tissue of rats with epilepsy induced by pentylenetetrazol. Chin Tradit Patent Med 34(4):726–728

    Google Scholar 

  54. Wang WQ, Wang SQ, Wang BX (2005) Effect of Ganoderma lucidum spore powder on cytokine IL-6 in brain tissue of epileptic rats. Heilongjiang Med Pharm 28(4):48–49

    Google Scholar 

  55. Zhao S, Wang SQ, Guo J, Zhang SC (2005) Effect of Ganoderma lucidum spore powder on TNF-α and ET-1 in hippocampus of rats with epilepsy. Heilongjiang Med Pharm 28(6):1–2

    Google Scholar 

  56. Zhang SG, Wang Y (2012) The effect of Reishi mushroom powder on protection of amygdala lighting model rat neurons and its mechanism. Chin J Biochem Pharm 33(2):145–147

    CAS  Google Scholar 

  57. Li J, Yu HB, Zhu YM, Wang SQ (2008) Effect of Ganoderma lucidum spore powder on electroencephalogram and IL-10 in rats with epilepsy. Heilongjiang Med Pharm 31(1):49–50

    Google Scholar 

  58. Zhao CX, Hao B (2013) Effect of Ganoderma lucidum spore powder on NGF in rats with pentylenetetrazol-induced epilepsy. J Mudanjiang Med Univ 34(2):27–29

    Google Scholar 

  59. Wang H, Wang SQ (2006) Effect of Ganoderma lucidum spore powder on the expression of BDNF in brain tissue of rats with epilepsy induced by pentylenetetrazol. Heilongjiang Med Pharm 29(2):5–7

    CAS  Google Scholar 

  60. Wang SQ, Li XJ, Zhou S, Sun DX, Wang H, Cheng PF (2013) Intervention effects of Ganoderma lucidum spores on epileptiform discharge hippocampal neurons and expression of neurotrophin-4 and N-cadherin. PLoS One 8(4):e61687

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Li J, Yu HB, Yu HT, Wang SQ, Wang WQ (2012) Effects of Ganoderma lucidum spores on Caspase-3, NO and NOS in rats with pentylenetetrazol-induced seizures. Chin Tradit Patent Med 34(10):2007–2008

    Google Scholar 

  62. Zhao S, Kang YM, Zhang SC, Wang SQ (2007) Effect of Ganoderma lucidum spores powder on the expression of IGF-1, NF-κB and apoptosis of nerve cells in the brain from epileptic rat. Chin J Pathophysiol 23(6):1153–1156

    CAS  Google Scholar 

  63. Zhang JB, Wang SQ, Zhang H, Zhang SH (2012) Study on the expression of bcl-2 in hippocampal neurons induced by pentylenetetrazol by Ganoderma lucidum spore powder. Heilongjiang Med Pharm 35(4):34–35

    CAS  Google Scholar 

  64. Zhang JB, Wang SQ, Zhang SH (2012) Study on the expression of bax in hippocampal neurons induced by pentylenetetrazol by Ganoderma lucidum spore powder. Chin J Birth Health Hered 12:27–28

    CAS  Google Scholar 

  65. Wang JL (2006) Effects of Ganoderma spore on the behavior and brain deprived neurotrophic factor in the striatum in the rats with mimic Huntington’s disease. Dissertation

    Google Scholar 

  66. Zhang W, Zeng YS (2005) Effects of Ganoderma spore on survival and expression of NT-3 and NOS of spinal motorneuron following ventral root cut in the rat. Acta Anatromica Sinica 36(5):471–476

    Google Scholar 

  67. Ma QT, Zeng YS, Zhang W (2005) Effects of Ganoderma spores and L-NNA on activity of mitochondrial cytochrome oxidase in Clarke’s nucleus after spinal cord injury. Chin J Histochem Cytochem 14(4):399–403

    Google Scholar 

Download references

Acknowledgments

Research in the authors’ laboratory is supported by National Natural Science Foundation of China grants 81620108029, 81330074, 81261160507, and 81170632, Beijing Natural Science Foundation grant 7172113, Drug Discovery Program grant 2009ZX09301-010-30, the Research Fund for the Doctoral Program of Higher Education 20100001110047, the 111 project, and International Science and Technology Cooperation Program of China 2012DFA11070.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Baoxue Yang .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Quan, Y., Ma, A., Yang, B. (2019). Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Brain Injury. In: Lin, Z., Yang, B. (eds) Ganoderma and Health. Advances in Experimental Medicine and Biology, vol 1182. Springer, Singapore. https://doi.org/10.1007/978-981-32-9421-9_6

Download citation

Publish with us

Policies and ethics